Literature DB >> 2971309

Cardiac function in systemic hypertension before and after reversal of left ventricular hypertrophy.

B Trimarco1, N De Luca, B Ricciardelli, G Rosiello, M Volpe, G Condorelli, G Lembo, M Condorelli.   

Abstract

In 3 age- and sex-matched groups of subjects--15 normotensives, 15 hypertensives without left ventricular (LV) hypertrophy and 15 hypertensives with LV hypertrophy--the slopes of the regression line obtained by plotting the individual values of LV fractional shortening against the corresponding values of echocardiographic end-systolic stress were compared. The first 2 groups were studied only in control conditions while the third group was restudied after a 20% reduction in LV mass index induced by a long-term antihypertensive treatment and after a 3-week washout period. A significant relation between fractional shortening and end-systolic stress was found in all instances. The slope of this correlation was higher in normotensives (-0.251) and in hypertensives without LV hypertrophy (-0.232) (both p less than 0.01) than in hypertensives with ventricular hypertrophy (-0.079). In this latter group, the slope increased after the reversal of LV hypertrophy (-0.230, p less than 0.01) and remained unchanged (-0.202) at the end of the washout period. No difference was detectable between the slopes obtained in these patients after reversal of LV hypertrophy, both with the antihypertensive treatment on and off, and those of normotensives and hypertensives without LV hypertrophy. Thus, LV hypertrophy attenuates the influence of changes in afterload on LV function. Reversal of LV hypertrophy restores a fractional shortening end-systolic stress relation quite comparable to that found both in normotensives and in hypertensives before the development of LV hypertrophy.

Entities:  

Mesh:

Year:  1988        PMID: 2971309     DOI: 10.1016/0002-9149(88)91215-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Risks versus benefits of withdrawing antihypertensive therapy.

Authors:  H P Schobel; R E Schmieder; F H Messerli
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

Review 2.  Management of hypertension in patients with left ventricular hypertrophy.

Authors:  Cesare Cuspidi; Carla Sala; Alberto Zanchetti
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

3.  Impact of left ventricular geometry on prognosis-a review of ochsner studies.

Authors:  Carl J Lavie; Richard V Milani; Sangeeta B Shah; Yvonne E Gilliland; Jose A Bernal; Homeyar Dinshaw; Hector O Ventura
Journal:  Ochsner J       Date:  2008

Review 4.  Effects of angiotensin converting enzyme inhibitors on left ventricular hypertrophy.

Authors:  C Morisco; L Argenziano; N Tozzi; A F Mele; B Ricciardelli; G Condorelli; B Trimarco
Journal:  Drugs       Date:  1993       Impact factor: 9.546

5.  Effects of bisoprolol on left ventricular hypertrophy in essential hypertension.

Authors:  E de Teresa; M González; C Camacho-Vázquez; M J Tabuenca
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

Review 6.  Angiotensin II receptor blockers and cardiovascular protection: focus on left ventricular hypertrophy regression and atrial fibrillation prevention.

Authors:  Cesare Cuspidi; Francesca Negri; Alberto Zanchetti
Journal:  Vasc Health Risk Manag       Date:  2008
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.